Literature DB >> 22871441

The production, separation, and use of 67Cu for radioimmunotherapy: a review.

Nicholas A Smith1, Delbert L Bowers, David A Ehst.   

Abstract

A review of the literature pertaining to the production and separation of (67)Cu. This isotope is useful from both therapeutic and diagnostic standpoints due to its medium energy beta particle, gamma emissions, and 2.6-day half-life. It has been produced via proton, neutron, and gamma irradiations on zinc followed by solvent extraction, ion exchange, electrodeposition, and/or sublimation. Widespread use of this isotope for clinical studies and preliminary treatments has been limited by unreliable supplies, cost, and difficulty in obtaining therapeutic quantities.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22871441     DOI: 10.1016/j.apradiso.2012.07.009

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  13 in total

Review 1.  Expanding the PET radioisotope universe utilizing solid targets on small medical cyclotrons.

Authors:  K J H George; S Borjian; M C Cross; J W Hicks; P Schaffer; M S Kovacs
Journal:  RSC Adv       Date:  2021-09-21       Impact factor: 4.036

2.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

3.  Feasibility of isotope harvesting at a projectile fragmentation facility: ⁶⁷Cu.

Authors:  Tara Mastren; Aranh Pen; Graham F Peaslee; Nick Wozniak; Shaun Loveless; Scott Essenmacher; Lee G Sobotka; David J Morrissey; Suzanne E Lapi
Journal:  Sci Rep       Date:  2014-10-21       Impact factor: 4.379

4.  Retracted: The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu.

Authors: 
Journal:  Biomed Res Int       Date:  2018-07-08       Impact factor: 3.411

5.  Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc.

Authors:  C Shaun Loveless; Lauren L Radford; Samuel J Ferran; Stacy L Queern; Matthew R Shepherd; Suzanne E Lapi
Journal:  EJNMMI Res       Date:  2019-05-16       Impact factor: 3.138

6.  Copper-67 radioimmunotheranostics for simultaneous immunotherapy and immuno-SPECT.

Authors:  Guiyang Hao; Tara Mastren; William Silvers; Gedaa Hassan; Orhan K Öz; Xiankai Sun
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

Review 7.  The copper radioisotopes: a systematic review with special interest to 64Cu.

Authors:  Artor Niccoli Asabella; Giuseppe Lucio Cascini; Corinna Altini; Domenico Paparella; Antonio Notaristefano; Giuseppe Rubini
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

8.  Pilot Study of 64Cu(I) for PET Imaging of Melanoma.

Authors:  Lei Jiang; Yingfeng Tu; Xiang Hu; Ande Bao; Hao Chen; Xiaowei Ma; Tim Doyle; Hongcheng Shi; Zhen Cheng
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

Review 9.  A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.

Authors:  Julie Bolcaen; Janke Kleynhans; Shankari Nair; Jeroen Verhoeven; Ingeborg Goethals; Mike Sathekge; Charlot Vandevoorde; Thomas Ebenhan
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

10.  Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy.

Authors:  Outi Keinänen; Kimberly Fung; James M Brennan; Nicholas Zia; Matt Harris; Ellen van Dam; Colin Biggin; Amos Hedt; Jon Stoner; Paul S Donnelly; Jason S Lewis; Brian M Zeglis
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-26       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.